These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38834088)

  • 41. Progress in pancreatic cancer: moving beyond gemcitabine?
    Basu B; Jodrell D
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):997-1000. PubMed ID: 23030218
    [No Abstract]   [Full Text] [Related]  

  • 42. Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.
    Fujita T
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577725
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Multimodal treatment of pancreatic cancer].
    Shalimov SA; Keĭsevich LV; Zakharov IB; Nichitaĭlo ME; Stasenko AA; Litvinenko AN; Vesnenko AI; Shalev VG
    Klin Khir (1962); 1991; (5):1-3. PubMed ID: 1714983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.
    Ahn DH; Ko AH; Meropol NJ; Bekaii-Saab TS
    Am Soc Clin Oncol Educ Book; 2015; ():e222-7. PubMed ID: 25993177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
    Mondo EL; Noel MS; Katz AW; Schoeniger LO; Hezel AF
    J Clin Oncol; 2013 Jan; 31(3):e37-9. PubMed ID: 23233707
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chemoradiotherapy for Locally Advanced Pancreatic Cancer].
    Okano N; Kawai K; Naruge D; Kitamura H; Nagashima F; Furuse J
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1152-5. PubMed ID: 26489544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How I treat ... An advanced pancreatic cancer].
    Polus M; Jerusalem G; Sautois B; Silvestre RM; Fillet G
    Rev Med Liege; 2002 Mar; 57(3):131-4. PubMed ID: 12014258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case.
    Turner K; Levi Sandri GB; Boucher E; Hénno S; Le Prisé E; Meunier B; Boudjema K; Sulpice L
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e29-31. PubMed ID: 25288453
    [No Abstract]   [Full Text] [Related]  

  • 50. A Rare Pancreatic Tumor That Underwent a Change in Morphology and Histopathologic Features During Chemotherapy.
    Seino S; Tsuchiya A; Natsui M
    Gastroenterology; 2016 Feb; 150(2):e11-3. PubMed ID: 26718170
    [No Abstract]   [Full Text] [Related]  

  • 51. Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.
    Strobel O; Büchler MW
    Nat Rev Gastroenterol Hepatol; 2013 Apr; 10(4):203-5. PubMed ID: 23478386
    [No Abstract]   [Full Text] [Related]  

  • 52. Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
    Bisht S; Brossart P; Feldmann G
    Oncol Res Treat; 2018; 41(10):590-594. PubMed ID: 30286472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodality treatment of locally advanced pancreatic cancer.
    Wagener DJ; de Mulder PH; Wils JA
    Ann Oncol; 1994; 5 Suppl 3():81-6. PubMed ID: 8204534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active Systemic Treatment of Pancreatic Cancer.
    Tempero M
    J Natl Compr Canc Netw; 2017 May; 15(5S):723-725. PubMed ID: 28515255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.
    Zhu J; Strosberg JR; Dropkin E; Strickler JH
    J Gastrointest Cancer; 2015 Jun; 46(2):166-9. PubMed ID: 25662891
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of polyplatillen in chemotherapy of advanced pancreatic cancer].
    Iatsenko LD; Lial'kin SA; Maĭdanevych NM
    Klin Khir; 2008 Jul; (7):20-3. PubMed ID: 19048815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pancreatic mass in a patient with nausea and vomiting. Extrapulmonary small cell carcinoma of the pancreas.
    Choi EH; Coyle W
    Gastroenterology; 2011 Mar; 140(3):e5-6. PubMed ID: 21276764
    [No Abstract]   [Full Text] [Related]  

  • 58. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
    Kourie HR; Gharios J; Kattan J
    Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
    [No Abstract]   [Full Text] [Related]  

  • 59. Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
    Giuliani J; Bonetti A
    Recenti Prog Med; 2017 Mar; 108(3):152-154. PubMed ID: 28398410
    [No Abstract]   [Full Text] [Related]  

  • 60. Preoperative chemoradiation therapy for pancreatic cancer.
    Evans DB; Pisters PW
    Surg Clin North Am; 2001 Jun; 81(3):709-13. PubMed ID: 11459284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.